abstract |
The invention concerns a monoclonal antibody capable of binding with a wild type HBsAg antigen and with at least one, preferably at least two and advantageously more than two, mutated forms of the HBsAg antigen, said monoclonal antibody binding with the peptide sequence consisting of at least 6 adjacent amino acids in the 199-208 region of the HBsAg antigen, and advantageously binding with the peptide sequence formed by the 199-208 region of the HBsAg antigen. |